Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


In a release issued this morning, Wednesday, June 30, 2021, under the same headline, byTheratechnologies Inc. (TSX: TH) (NASDAQ: THTX), please note that in the last sentence of the first paragraph, the date should be Thursday, July 15, 2021, not Wednesday July 15, 2021. The corrected release follows:


GlobeNewswire Inc | Jun 30, 2021 11:28AM EDT

June 30, 2021

MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- In a release issued this morning, Wednesday, June 30, 2021, under the same headline, byTheratechnologies Inc. (TSX: TH) (NASDAQ: THTX), please note that in the last sentence of the first paragraph, the date should be Thursday, July 15, 2021, not Wednesday July 15, 2021. The corrected release follows:

Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced today that it will report its financial results for the second quarter of fiscal 2021 ended May 31, 2021 on Thursday, July 15, 2021.

The Company will host a conference call and webcast at 8:30 a.m. (ET) to discuss the results hosted by Paul Lvesque, President and Chief Executive Officer.

The conference call can be accessed by dialing 1-844-400-1697 (toll free) or 1-703-736-7400 (International). The conference call will also be accessible via webcast at https://edge.media-server.com/mmc/p/d9fu3xjc . Phone replay report of the conference call will be available on the same day starting at 11:30 a.m. (ET) until July 22, 2021, by dialing 1-855-859-2056 (North America) or 1-404-537-3406 (International) and by entering the access code: 7943345. The webcast replay is also available until July 15, 2022 on https://edge.media-server.com/mmc/p/d9fu3xjc

About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:Denis BoucherVice President, Communications and Corporate Affairs514-336-7800

For investor inquiries:Leah GibsonSenior Director, Investor Relations617-356-1009ir@theratech.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC